Korro Bio Appoints Interim CFO Amid Medical Leave

Korro Bio ( (KRRO) ) has provided an announcement.

Effective February 11, 2025, Korro Bio, Inc. announced that Vineet Agarwal, the company’s Chief Financial Officer, will be taking a temporary medical leave of absence. In his absence, the Board of Directors has appointed Dr. Ram Aiyar, the President and CEO, as interim principal financial officer, and Mr. Oliver Dolan, Senior Vice President of Finance, as interim principal accounting officer. This reshuffling of responsibilities is a strategic move to ensure continuity in leadership and maintain operational stability during Agarwal’s absence.

More about Korro Bio

YTD Price Performance: -21.43%

Average Trading Volume: 102,934

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $324.3M

For detailed information about KRRO stock, go to TipRanks’ Stock Analysis page.